BIOMAT Database Logo BIOMAT Database Logo

Induction chemotherapy of non-Hodgkin's malignant lymphomas. Preliminary results of a controlled trial. 1977

J Chauvergne, and M Durand, and B Hoerni, and G Hoerni-Simon, and R Brunet, and C Lagarde

UI MeSH Term Description Entries
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J Chauvergne, and M Durand, and B Hoerni, and G Hoerni-Simon, and R Brunet, and C Lagarde
Sequential versus alternating chemotherapy for high-grade non-Hodgkin's lymphomas: preliminary results of a phase III multicentre trial.
February 1990, Onkologie,
J Chauvergne, and M Durand, and B Hoerni, and G Hoerni-Simon, and R Brunet, and C Lagarde
[Non-Hodgkin's lymphomas. Results of alternating chemotherapy versus sequential chemotherapy].
August 1990, Sangre,
J Chauvergne, and M Durand, and B Hoerni, and G Hoerni-Simon, and R Brunet, and C Lagarde
Treatment of advanced non-Hodgkin's lymphomas with favorable histologies: preliminary results of a prospective trial.
May 1976, Blood,
J Chauvergne, and M Durand, and B Hoerni, and G Hoerni-Simon, and R Brunet, and C Lagarde
[Malignant Hodgkin's and non-Hodgkin's lymphomas].
March 2005, MMW Fortschritte der Medizin,
J Chauvergne, and M Durand, and B Hoerni, and G Hoerni-Simon, and R Brunet, and C Lagarde
Adjuvant therapy by BCG of non-Hodgkin's malignant lymphomas in a controlled trial: an update.
January 1989, British journal of haematology,
J Chauvergne, and M Durand, and B Hoerni, and G Hoerni-Simon, and R Brunet, and C Lagarde
Chemotherapy of non-Hodgkin's lymphomas.
January 1991, Bailliere's clinical haematology,
J Chauvergne, and M Durand, and B Hoerni, and G Hoerni-Simon, and R Brunet, and C Lagarde
[Chemotherapy of non-Hodgkin's lymphomas].
September 1982, Wiener klinische Wochenschrift,
J Chauvergne, and M Durand, and B Hoerni, and G Hoerni-Simon, and R Brunet, and C Lagarde
Combination chemotherapy of the malignant lymphomas: a controlled clinical trial.
September 1976, Cancer,
J Chauvergne, and M Durand, and B Hoerni, and G Hoerni-Simon, and R Brunet, and C Lagarde
Laparotomy staged I and II non-Hodgkin's lymphomas: preliminary results of radiotherapy and adjunctive chemotherapy.
January 1980, Cancer,
J Chauvergne, and M Durand, and B Hoerni, and G Hoerni-Simon, and R Brunet, and C Lagarde
[Malignant lymphomas. Non-Hodgkin's lymphomas (NHL). I].
March 1980, Minerva medica,
Copied contents to your clipboard!